Clinical Trial Update: Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage [Phase 2]

View source ↗

Summary

Phase 2 results for the MOAD regimen (methotrexate, vincristine, pegylated L-asparaginase and dexamethasone) in salvage therapy for acute lymphoblastic leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• METHOTREXATE (METHOTREXATE)
• Pegaspargase (pegaspargase)
• Vincristine (vincristine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia, Lymphocytic, Acute | Phase 2 | Status: COMPLETED | Results posted: 2015-06-29